期刊文献+

规范肥胖及2型糖尿病的外科治疗——解读2013版外科减重手术指南 被引量:9

原文传递
导出
摘要 在美国,肥胖一直是一个重大的公共卫生问题,2009至2010年,有超过1/3的成年人符合肥胖[依据体质指数(BMI)≥30 kg/m2]标准[1].肥胖不仅是致死的高危因素,还会产生身心合并症.实际上,肥胖应被视为一种疾病状态[2-3].非手术治疗能使患者体重减轻5%~10%,并改善严重肥胖者的健康状态.而减重手术适用于临床重度肥胖患者[4].目前,减重手术已被认为是治疗肥胖最成功、最持久的方法.此外,虽然整体肥胖率和减重手术趋于稳定,但是重度肥胖患者在美国仍在继续增加,现在大约有1 500万BMI≥40 kg/m2的人群[1,5].在适合手术的肥胖者中,只有1%接受了手术治疗.
作者 刘金钢
出处 《中华糖尿病杂志》 CAS CSCD 2014年第3期194-197,共4页 CHINESE JOURNAL OF DIABETES MELLITUS
  • 相关文献

参考文献21

  • 1Ogden CL, Carroll MD, Kit BK, the United States, 2009-2020 [ J ] 1-8. et al. Prevalence of obesity in NCHS Data Brief, 2012,82 :.
  • 2Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body- mass index and mortality among 1.46 million white adults [ J ]. N Engl J Med,2010,363 :2211-2219.
  • 3Mechanick JI, Garber A J, Handelsman Y, et al. American Association of Clinical Endocrinologists (AACE) position paper on obesity and obesity medicine [ J ]. Endocr Pract, 2012, 18: 642-648.
  • 4Ryan DH, Johnson WD, Myers VH, et al. Nonsurgieal weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study [ J]. Arch Intern Med, 2010, 170 : 146-154.
  • 5Livingston EH. The incidence of bariatrie surgery has plateaued in the U. S[JI. Am J Surg, 2010,200:378-385.
  • 6Meehanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and the American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient [J]. Endocr Pract, 2008,14 Suppl 1 :S1-83.
  • 7American Society for Metabolic Bariatric Surgery. Updated position statement on sleeve gastrectomy as a bariatrie procedure[ EB/OL]. [2013-12-23 ]. http://www, thinnertimesforum, com/topic/65864- october-2011 -sleeve-gastrectomy-position-statement -fromasmbs/.
  • 8Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoseopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass[ J]. Ann Surg,2011, 254:410-420.
  • 9O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program : a randomized, trial [ J 1. Ann Intern Med, 2006,144:625-633.
  • 10Sultan S, Parikh M, Youn H, et al. Early U.S. outcomes after laparoscopic adjustable gastric banding in patients with a body mass index less than 35 kg/m2 [ J:. Surg Endosc,2009,23 : 1569- 1573.

同被引文献81

  • 1Fan, JG,Li, F,Cai, XB,Peng, YD,Ao, QH,Gao, Y.Effects of nonalcoholic fatty liver disease on the development of metabolic disorders[J].中国生物学文摘,2007,21(11):21-22. 被引量:52
  • 2Anstee QM,Targher G,Day CP.Progression of NAFLD to diabetes mellitus,cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol . 2013
  • 3Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes[J]. N Engl J Med, 2012, 366(17): 1577-1585.
  • 4Hutter MM, Sehirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass [J]. Ann Surg, 2011, 254: 410-420.
  • 5Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes[J]. N Engl J Med, 2012, 366(17): 1567- 1576.
  • 6Cui JF, Chela T, Shi L, et al. Gastric bypass surgery in non-obese patients with type 2 diabetes mellitus:a 1-year follow-up 58 cases in chinese [J]. Int J Clin Exp Med, 2015,8 ( 3 ) : 4393-4396.
  • 7Isbell JM, Tamboli RA, Hansen EN, et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery[J]. Diabetes Care, 2010, 33(7): 1438-1442.
  • 8Richard J. Johnson,Duk-Hee Kang,Daniel Feig,Salah Kivlighn,John Kanellis,Susumu Watanabe,Katherine R. Tuttle,Bernardo Rodriguez-Iturbe,Jaime Herrera-Acosta,Marilda Mazzali.Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?[J].Hypertension: Journal of the American Heart Association.2003(6)
  • 9Diem P, Fricke A, Sander L, et al. Mieroparticles: major transport vehicles for distinct microRNAs in circulation[J]. Cardiovasc Res, 2012,93:633-644.
  • 10Csongr6di l~, Nagy B Jr, Fulop T, et al. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients[J]. Thromb Haemost,2011,106:683-692.

引证文献9

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部